Kenneth Gersing, Informatics Director, NCATS, NIH; Joseph Ross, Professor of Medicine and Public Health, Yale University; Patroula Smpokou, Clinical Team Leader, Rare/Genetic Diseases, FDA; Jacqueline Corrigan-Curay, Director, CDER Office of Medical Polic
Kenneth Gersing, M.D., informatics director, NCATS, NIH; Joseph Ross, M.D., M.H.S., professor of medicine and public health, Yale University; Patroula Smpokou, M.D., clinical team leader, rare/genetic diseases, FDA; Jacqueline Corrigan-Curay, J.D., M.D., director, CDER Office of Medical Policy, FDA; Clare Thibodeaux, Ph.D., director of scientific affairs, Cures Within Reach; and Matt Might, Ph.D., director, Hugh Paul Precision Medicine Initiative, hold a panel discussion on The Clinical Experience Spectrum at the Repurposing Off-Patent Drugs: Research & Regulatory Challenges Workshop.
Credit: National Center for Advancing Translational Sciences
Kenneth Gersing, Informatics Director, NCATS, NIH; Joseph Ross, Professor of Medicine and Public Health, Yale University; Patroula Smpokou, Clinical Team Leader, Rare/Genetic Diseases, FDA; Jacqueline Corrigan-Curay, Director, CDER Office of Medical Polic
Kenneth Gersing, M.D., informatics director, NCATS, NIH; Joseph Ross, M.D., M.H.S., professor of medicine and public health, Yale University; Patroula Smpokou, M.D., clinical team leader, rare/genetic diseases, FDA; Jacqueline Corrigan-Curay, J.D., M.D., director, CDER Office of Medical Policy, FDA; Clare Thibodeaux, Ph.D., director of scientific affairs, Cures Within Reach; and Matt Might, Ph.D., director, Hugh Paul Precision Medicine Initiative, hold a panel discussion on The Clinical Experience Spectrum at the Repurposing Off-Patent Drugs: Research & Regulatory Challenges Workshop.
Credit: National Center for Advancing Translational Sciences